Cell Culture Media Market

Market Study on Cell Culture Media: High Demand for Stem Cells and Tissue Engineering Aiding Market Expansion

Cell Culture Media Market Segmented By Serum-Containing Media, Serum-Free Media, Protein-Free Media, Chemically-Defined Media product for Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, Stem Cell Technologies Application

  • November-2021
  • PMRREP31338
  • 200 Pages
  • Healthcare

Market Snapshot

The global cell culture media market was valued at US$ 2.6 Bn in 2020, and is projected to reach a valuation of US$ 5.6 Bn by 2031, reflecting a CAGR of 7.1% over the forecast period (2021-2031), according to the recent detailed Persistence Market Research study.

Sales of cell culture media accounts for approximately 15% of the global cell culture products market. Cell culture media, also known as tissue culture media, is expected to have good potential for growth in cancer research applications. Growth of the tissue engineering market is expected to proportionately boost market growth.

Development of technologies such as 3D cell culture, organoids, and microfluidics is expected to further promote market growth. Furthermore, developments in the field of stem cell research and stem cell therapies are expected to have a positive influence on the overall market for cellular growth.

Increase in biopharmaceutical production is also driving cell culture media demand due to its wide range of applications, such as in the manufacturing of vaccines, blood and blood-components, proteins for allergy treatment, and cells used in different therapies such as cell therapies, gene therapies, and recombinant therapeutic proteins.

Advancements in the biotechnology sector are thus expected to offer lucrative growth opportunities for cell culture media manufacturers over the coming years.

Cell Culture Media Market Value (2020)

US$ 2.6 Bn

Forecasted Market Value (2031)

US$ 5.6 Bn

Market Growth (2021-2031)

7.1% CAGR

Key Cell Culture Media Providers

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza
  • Corning Incorporated

Find Out More about the Report Coverage


  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza
  • Corning Incorporated
  • Irvine Scientific
  • STEMCELL Technologies Inc
  • PAN Biotech
  • MP Biomedicals, LLC
  • PromoCell GmbH
  • Becton, Dickinson and Company
  • Hi-Media Laboratories

Cell Culture Media Demand Analysis from 2016-2020 Vs Market Outlook for 2021-2031

According to Persistence Market Research, sales of cell culture media increased at a CAGR of 4.7% from 2016 to 2020. Increasing research & development in the life sciences field and favorable government policies and funding are expected to drive sales of cell culture media by providing the manufacturers with a great opportunity to invest in the field, which also provides positive impetus to the market for growth media.

Persistence Market Research expects demand for cell culture media to increase at a high CAGR of 7.1% through 2031. Growth is attributed to increasing research & development activities in the life sciences sector and major companies actively participating in approvals, partnerships, collaborations, and acquisitions to increase their market presence and strengthen their product portfolios.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Will Increasing Production of Antibodies for Treatment of Diseases Drive Demand for Cell Culture Media?

With increasing development of monoclonal antibodies, use of cell culture media is also increasing. Side effects in the case of antibody drugs are low due to the high specificity of antibodies. Thus, therapeutic antibodies are the major class of new drugs developed in the last few years.

Therapeutic antibodies got approval as a reliable treatment option for various diseases such as cancer, autoimmune disorders, metabolic disorders, and infectious diseases. For instance, according to a research article in the Journal of Biomedical Science, in December 2019, 79 therapeutic mAbs were approved by the US FDA.

As these monoclonal antibodies are produced through various cell culture media, it bodes well for market growth over the coming years.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

What are the Key Opportunities for Cell Culture Media Providers?

Product innovation by key players and agreements, partnerships, and collaborations among leading manufacturers of cell culture media have emerged as key growth strategies in the market. Acquisitions significantly accelerate manufacturers’ strategy to capitalize on the market share and capture a significant share of the market.

  • For instance, in May 2017, Lonza acquired PharmaCell B.V., a cell and gene contract manufacturers in Europe.

Favorable government policies and increasing funding by governments in the life sciences sector are also expected to boost cell culture media demand in the near future.

  • For instance, according to Congressional Budget Office, the pharmaceutical industry spent 83 billion dollars on R&D in 2019.

Thus, the above-mentioned factors are creating huge opportunities for cell culture media suppliers.


Explore Persistence Market Research’s expertise in promulgation of the business !

Country-wise Insights

Will the U.S. Remain a Key Market for Cell Culture Media?

In 2021, the U.S. is estimated to account for approximately 91% value share in the North America market. Demand for cell culture media is rising due to rising number of biopharmaceutical and biotechnology companies in the country, such as Celgene Corporation and Biogen Inc.

Why is Germany Considered a Lucrative Market for Cell Culture Media in Europe?

Germany is expected to account for 27.5% market share in Europe in 2031. Rise in demand for cell culture media in Germany is primarily due to increasing prevalence of cancer in the country.

For instance, according to the World Cancer Research Fund, there were 313.1 cases per 100,000 people in 2018 in Germany, which portrays the importance of cell culture media for cancer treatment and research.

Which Factors are Supporting Cell Culture Media Sales in China?

The China market is expected to account for around 8.5% CAGR throughout the forecast period. This high rate of growth is primarily due to increasing number of clinical trials in the country.

For instance, there is an active clinical trial going at the Chinese PLA General Hospital on the topic of mesenchymal stem cell-conditioned medium-derived pleiotropic factor in treating residual burn wounds.

Category-wise Insights

Why is Demand for Serum-Free Media Rising Rapidly?

In terms of cell culture media types, serum-free media holds a high share of around 51%, and is more sought-after as compared to serum-containing media. The segment is set to expand at 6.8% CAGR over the forecast period.

Serum-free media has advantages such as more reliable performance, increased growth, and reduced risk of contamination by serum-borne agents in cell culture that occur accidentally.

Why is Cell Culture Media Important for Cancer Research?

By application, cancer research accounts for 43.7% of the market share for media and supplements in cell culture, indicating that demand for cell culture media as a growth medium is rising in the cancer research industry, because with rising cases of cancer, demand for cancer treatment-related research is also increasing.

Impact of COVID-19 Crisis

Due to COVID 19, there has been a gradual increase in market growth across the product segment for cell culture media components. This growth was seen due to rising demand for vaccine development and bio-therapeutics during the COVID-19 pandemic.

However, lockdowns due to COVID-19 led to disruptions in the supply chain and discontinued business operations, which left many biopharma companies waiting for the availability of new batches of raw material for cell culture media preparation. But steady growth is expected over the coming years as the pandemic subsides gradually.

Competitive Landscape

Companies supplying cell culture media are actively seeking to strengthen their position through approvals, collaborations, acquisitions, partnerships, and agreements with established as well as emerging market players.

Some of the recent instances include:

  • In August 2017, Thermo Fisher Scientific Inc. announced that it had completed the acquisition of Patheon N.V., a leading Contract Development and Manufacturing Organization (CDMO) that aids the pharmaceutical and biotechnology sectors.
  • In September 2017, Sanofi and Lonza collaborated to build and operate a large-scale mammalian cell culture facility for the production of monoclonal antibodies.
  • In June 2020, Lonza collaborated with CELLINK for offering a comprehensive 3-D bio-printing solution that is aimed to advance complete 3D cell culture workflows.

Cell Culture Media Industry Report Scope



Forecast Period


Historical Data Available for


Market Analysis

USD Million for Value.

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand
  • GCC Countries
  • Turkey
  • South Africa

Key Segments Covered

  • Product
  • Matrix
  • Application
  • End User
  • Region

Report Coverage

  • Market Forecasts
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Cell Culture Media Industry Survey


  • Serum-Containing Media
  • Serum-Free Media
    • Protein Expression Media
    • Stem Cell Media
    • Hybridoma Media
    • Primary Cell Media
    • Insect Cell Media
    • Immunology Media
    • CHO Cell Culture Media
  • Protein-Free Media
  • Chemically-Defined Media


  • Cell Culture Media for Cancer Research
  • Cell Culture Media for Biopharmaceuticals
  • Cell Culture Media for Regenerative Medicine & Tissue Engineering
  • Cell Culture Media for Stem Cell Technologies
  • Others

End User

  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Research Centers
  • Middle-East & Africa

Media Release

- FAQs -

The global cell culture media market was worth US$ 2.6 Bn in 2020, and is set to expand more than 2X over the next ten years.

The market is expected to reach a valuation of US$ 5.6 Bn by the end of 2031, with sales revenue expected to register a CAGR of 7.1%.

Sales of cell culture media increased at a CAGR of 4.7% from 2016 to 2020.

Increasing collaborations between contract manufacturing organizations, growing biopharmaceutical production, and presence of key players are major trends across the globe.

The U.S., China, Germany, U.K., and Japan are the top 5 countries driving demand for cell culture media.

North America currently holds 32.6% share in the global market, with the U.S. being the leading contributor with a market value of US$ 841.9 Mn in 2021.

Europe currently holds 29.7% share of the global market for cell culture media.

Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Lonza, Corning Incorporated, and STEMCELL Technologies Inc. are key manufacturers of cell culture media.

Japan holds a market share of 76.7% in the East Asia market for cell culture media, while the rest in held by South Korea.


Health Caregiving Market

Global health caregiving market was pegged at more than US $ 70 Bn in 2015 & is estimated to cross US $ 200 bn by the end of 2024, registering a CAGR of 12.6%.

Antibodies Contract Manufacturing Market

The global antibodies contract manufacturing market was valued at US$ 3.87 Bn in 2020, and is expected to register a high CAGR of 13% during the forecast period (2021-2031)..

Humanized Mice Model Market

Humanized Mice Model Market is projected to exhibit a CAGR of 6.0% from 2017 to 2026. In 2017, the market was worth US$ 67.5 Mn and it has been estimated that it will touch a valuation of US$ 113.5 Mn by the end of 2026..

Oncolytic Virus Immunotherapy Market

In terms of value, North America is estimated to be the prominent region for the global oncolytic virus immunotherapy market in 2019 and is expected to grow at a significant cagr over the predefined timeframe, owing to the high prevalence of cancer, specifically melanoma cancer in the region..

Our Clients

Our Clients